Last Updated: Tuesday, March 18, 2014, 11:31
India supplies about 40 percent of generic and over-the-counter drugs used in the United States, making it the second-biggest supplier after Canada.
Last Updated: Monday, February 10, 2014, 10:21
In November, the U.S. Food and Drug Administration issued an import alert, effectively a ban, against Wockhardt's Chikalthana plant in western India.
Last Updated: Wednesday, February 05, 2014, 22:11
Ranbaxy Laboratories Ltd has been hit by more regulatory scrutiny sparked by a U.S. ban on the bulk of its drugs, in a backlash that could bump up compliance costs and erode profitability among some Indian makers of generic drugs.
Last Updated: Wednesday, December 04, 2013, 09:53
Of late, the FDA has targeted the largest Indian drug manufacturing producers including Ranbaxy.
Last Updated: Wednesday, November 27, 2013, 15:46
In a filing to the BSE, the company said it has received a warning letter from USFDA for its manufacturing units located at L1, Chikalthana, Aurangabad and B15, Waluj, Aurangabad.
Last Updated: Wednesday, November 27, 2013, 11:36
A second plant operated by generic drugmaker Wockhardt Ltd was hit by the U.S. Food and Drug Administration with an "import alert", effectively a ban, clouding the company's earnings outlook and sending its shares down as much as 13.5 percent.
Last Updated: Tuesday, November 26, 2013, 18:32
Realty firm Unitech's scrip tanked 7.67 percent to settle at Rs 15.65, while drug major Wockhardt lost 4.06 percent to end the day at Rs 472.
Last Updated: Thursday, November 07, 2013, 21:52
Leading stock exchange NSE has revised circuit limits for shares of 1,439 companies, including Kingfisher Airlines, Muthoot Finance, Wockhardt, Reliance MediaWorks, as part of its surveillance action.
Last Updated: Friday, October 25, 2013, 15:01
The company had posted a consolidated net profit of Rs 453.55 crore in the same quarter last fiscal.
Last Updated: Tuesday, October 22, 2013, 14:02
UK's health regulator has imposed restrictions on import of medicines made at Wockhardt's unit at Kadaiya in Nani Daman for violation of norms, the second plant of the firm to face such action in as many weeks.
Last Updated: Saturday, October 05, 2013, 23:25
Madras High Court on Saturday directed the concerned Drugs Controller to take inventory of banned dextropropoxyphene, a pain killer, held in the warehouses of its manufacturer Wockhardt and distributors within two weeks and keep them sealed separately.
Last Updated: Tuesday, September 24, 2013, 15:43
The US health regulators, which has been cracking the whip against many Indian pharmaceutical firms, including Ranbaxy Laboratories and Wockhardt, is also recruiting and training additional drugs investigators in India.
more videos >>